Effects on Trypanosoma brucei differentiating bloodstream trypomastigotes and established procyclic trypomastigotes when grown in the presence of respiratory inhibitors.
D000818:Animals; D000968:Antimycin A / Q000494:pharmacology; D003580:Cytochromes / Q000378:metabolism; D004579:Electron Transport; D003576:Electron Transport Complex IV / Q000037:antagonists & inhibitors / Q000378:metabolism*; D005993:Glycerolphosphate Dehydrogenase / Q000037:antagonists & inhibitors / Q000378:metabolism*; D011190:Potassium Cyanide / Q000494:pharmacology; D012457:Salicylamides / Q000494:pharmacology; D014346:Trypanosoma brucei brucei / Q000187:drug effects / Q000201:enzymology* / Q000254:growth & development
D003580:Cytochromes; D012457:Salicylamides; D000968:Antimycin A; C005703:salicylhydroxamic acid; D005993:Glycerolphosphate Dehydrogenase; C036140:L-alpha-glycerol-phosphate oxidase; D003576:Electron Transport Complex IV; D011190:Potassium Cyanide